Injected 'Nanodiscs' Could Bring Brain Stimulation Therapy Without Implants
By Dennis Thompson HealthDay Reporter
FRIDAY, Oct. 11, 2024 -- Microscopic magnetic nanodiscs could provide a much less invasive means of providing deep brain stimulation, a new study says.
The tiny discs – about 250 nanometers across, or 1/500 the width of a human hair – would be injected directly into specific regions of a person’s brain, researchers say.
From there, researchers said, the discs could be activated by applying a magnetic field outside the patient’s body.
Tests in lab mice show that the discs “had an impact on neuron activity and on behavior,” researcher Ye Ji Kim, a doctoral student at MIT, said in a news release.
Deep brain stimulation uses electrodes implanted in target brain regions to treat conditions like Parkinson’s disease, epilepsy, obsessive-compulsive disorder, tremors and Tourette syndrome, the Mayo Clinic says.
But placing the implants involves major brain surgery, which opens patients up to a number of harmful complications, researchers noted.
These nanodiscs could provide a less invasive alternative to currently used electrodes, researchers said.
The nanodiscs contain a magnetic core and an electrically charged outer shell. When exposed to a magnet, the core presses against the outer shell and causes it to deliver electrical pulses to nearby neurons, researchers said.
Stimulation can be switched on and off by flipping a switch on an electromagnet, researchers said.
The discs successfully stimulated brain regions in mice associated with feelings of reward and motor control, researchers report.
This included the subthalamic nucleus, “the region where electrodes typically get implanted to manage Parkinson’s disease,” Kim explained.
However, researchers say the discs need more work to make them powerful enough to provide the sort of brain stimulation needed to treat human illnesses. And experts stress that research done in animals often has different results in people.
“Yes, it’s a record-breaking particle, but it’s not as record-breaking as it could be,” senior researcher Polina Anikeeva, a professor of materials science and engineering and brain and cognitive sciences at MIT, said in a news release.
“When we find that these particles are really useful in a particular clinical context, then we imagine that there will be a pathway for them to undergo more rigorous large animal safety studies,” Anikeeva added.
The new study was published Oct. 11 in the journal Nature Nanotechnology.
Sources
- MIT, news release, Oct. 11, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Common Meds Appear To Delay Onset Of Parkinson's Disease
THURSDAY, April 17, 2025 -- Common medications like aspirin, ibuprofen, statins and beta blockers appear to slow the progress of Parkinson’s disease, a new study...
Fathers With Alzheimer's Might Pass Down The Disease, Study Says
THURSDAY, April 10, 2025 -- Having a father with Alzheimer’s disease could put you at risk for brain changes linked to the degenerative disorder, a new study...
Powerful MRI Scans Aid Epilepsy Surgery
WEDNESDAY, March 26, 2025 -- The first sign of seizures for Amanda Bradbury were auras in her vision that cropped up around age 19. Then came frequent bouts of anxiety...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.